The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany
Sroczynski G, Esteban E, Engel J, Hillemanns P, Petry K-U, Krämer A, Schnell-Inderst P, Muehlberger N, Siebert U (2013)
In: Value in Health. Value in Health, 16(7). New York: Elsevier: A574-A575.
Kurzbeitrag Konferenz / Poster
| Veröffentlicht | Englisch
Download
Es wurden keine Dateien hochgeladen. Nur Publikationsnachweis!
Autor*in
Sroczynski, G.;
Esteban, E.;
Engel, J.;
Hillemanns, P.;
Petry, K. -U;
Krämer, AlexanderUniBi 
;
Schnell-Inderst, P.;
Muehlberger, N.;
Siebert, U.
;
Schnell-Inderst, P.;
Muehlberger, N.;
Siebert, U.Einrichtung
Erscheinungsjahr
2013
Titel des Konferenzbandes
Value in Health
Serien- oder Zeitschriftentitel
Value in Health
Band
16
Ausgabe
7
Seite(n)
A574-A575
ISSN
1098-3015
Page URI
https://pub.uni-bielefeld.de/record/2642109
Zitieren
Sroczynski G, Esteban E, Engel J, et al. The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany. In: Value in Health. Value in Health. Vol 16. New York: Elsevier; 2013: A574-A575.
Sroczynski, G., Esteban, E., Engel, J., Hillemanns, P., Petry, K. - U., Krämer, A., Schnell-Inderst, P., et al. (2013). The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany. Value in Health, Value in Health, 16, A574-A575. New York: Elsevier. https://doi.org/10.1016/j.jval.2013.08.1554
Sroczynski, G., Esteban, E., Engel, J., Hillemanns, P., Petry, K. -U, Krämer, Alexander, Schnell-Inderst, P., Muehlberger, N., and Siebert, U. 2013. “The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany”. In Value in Health, 16:A574-A575. Value in Health. New York: Elsevier.
Sroczynski, G., Esteban, E., Engel, J., Hillemanns, P., Petry, K. - U., Krämer, A., Schnell-Inderst, P., Muehlberger, N., and Siebert, U. (2013). “The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany” in Value in Health Value in Health, vol. 16, (New York: Elsevier), A574-A575.
Sroczynski, G., et al., 2013. The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany. In Value in Health. Value in Health. no.16 New York: Elsevier, pp. A574-A575.
G. Sroczynski, et al., “The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany”, Value in Health, Value in Health, vol. 16, New York: Elsevier, 2013, pp.A574-A575.
Sroczynski, G., Esteban, E., Engel, J., Hillemanns, P., Petry, K.-U., Krämer, A., Schnell-Inderst, P., Muehlberger, N., Siebert, U.: The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany. Value in Health. Value in Health. 16, p. A574-A575. Elsevier, New York (2013).
Sroczynski, G., Esteban, E., Engel, J., Hillemanns, P., Petry, K. -U, Krämer, Alexander, Schnell-Inderst, P., Muehlberger, N., and Siebert, U. “The Benefit-Harm Frontier of Different Primary Screening Strategies for Cervical Cancer in Germany”. Value in Health. New York: Elsevier, 2013.Vol. 16. Value in Health. A574-A575.
Export
Markieren/ Markierung löschen
Markierte Publikationen
Web of Science
Dieser Datensatz im Web of Science®Suchen in
Google Scholar